Targeting the lysine lactylome for the treatment of glioma
Cancer Biol Med
.
2024 Dec 30:j.issn.2095-3941.2024.0461.
doi: 10.20892/j.issn.2095-3941.2024.0461.
Online ahead of print.
Authors
Di Wang
1
2
,
Guanzhang Li
2
3
4
,
Tao Jiang
1
2
3
4
5
6
7
8
,
Wei Zhang
1
2
3
4
5
6
7
8
Affiliations
1
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.
2
Clinical Center for Glioma, Capital Medical University, Beijing 100070, China.
3
Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China.
4
Beijing Engineering Research Center of Targeted Drugs and Cell Therapy for CNS Tumors, Beijing 102600, China.
5
Brain Tumor Center, Beijing Institute of Brain Disorders, Beijing 100069, China.
6
China National Clinical Research Center for Neurological Diseases, Beijing 100070, China.
7
National Center for Neurological Disorders, Beijing 100070, China.
8
Chinese Glioma Genome Atlas Network (CGGA) and Asian Glioma Genome Atlas Network (AGGA), Beijing 100070, China.
PMID:
39749761
DOI:
10.20892/j.issn.2095-3941.2024.0461
No abstract available
Grants and funding
82072768/National Natural Science Foundation of China
055/Youth Beijing Scholar
JWZQ20240101026/The Outstanding Young Scientist Program of Beijing Universities
BRWEP2024W032040200/Beijing Municipal Health Commission Research Ward Excellence Clinical Research Program